Compare · BMGL vs CHE
BMGL vs CHE
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.78B, about 748.5x BMGL ($9.1M).
- Over the past year, BMGL is down 80.7% and CHE is up 9.5% - CHE leads by 90.2 points.
- BMGL has hit the wire 3 times in the past 4 weeks while CHE has been quiet.
- CHE has more recent analyst coverage (6 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- Chemed Corp
- Price
- $5.19-16.29%
- $510.52+1.67%
- Market cap
- $9.1M
- $6.78B
- 1M return
- -25.05%
- +14.12%
- 1Y return
- -80.69%
- +9.47%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 3
- 0
- Recent ratings
- 0
- 6
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest BMGL
- SEC Form 3 filed by new insider Neo Alton Chun How
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- BMGL to Effect Reverse Share Split on June 22, 2026
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
Latest CHE
- Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
- SEC Form 11-K filed by Chemed Corp
- Director Lindell Andrea R sold $602,554 worth of Capital Stock (1,347 units at $447.33), decreasing direct ownership by 23% to 4,578 units (SEC Form 4)
- Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)